Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
VI Peel
- Development stage
- Unknown
- Lead developer
- VI Peel
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
VI Peel is a medium-depth chemical peel developed by the Vitality Institute. It consists of a synergistic blend of active ingredients, including trichloroacetic acid (TCA), phenol, salicylic acid, retinoic acid, and ascorbic acid (Vitamin C). The formulation works through keratolytic and kerato-coagulation mechanisms to promote desquamation and cellular renewal. It is primarily indicated for the treatment of photoaging, fine lines, wrinkles, acne, and hyperpigmentation. Clinical studies have explored its safety and efficacy when used in combination with other cosmetic treatments like botulinum toxin type A.
- Brand names
- VI Peel
- Other names
- Vitality Institute Peel
02
Targets
RAR (Retinoic acid receptor)
Beyond the preview
Go deeper on VI Peel.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VI Peel.